ATE335732T1 - 4-imidazol-1-ylmethylpyrimidinderivate als liganden für gabaa-rezeptoren - Google Patents

4-imidazol-1-ylmethylpyrimidinderivate als liganden für gabaa-rezeptoren

Info

Publication number
ATE335732T1
ATE335732T1 AT03810562T AT03810562T ATE335732T1 AT E335732 T1 ATE335732 T1 AT E335732T1 AT 03810562 T AT03810562 T AT 03810562T AT 03810562 T AT03810562 T AT 03810562T AT E335732 T1 ATE335732 T1 AT E335732T1
Authority
AT
Austria
Prior art keywords
sub
receptors
ligands
gaba
cns
Prior art date
Application number
AT03810562T
Other languages
English (en)
Inventor
Linghong Xie
Bingsong Han
Yuelian Xu
George Maynard
Original Assignee
Neurogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp filed Critical Neurogen Corp
Application granted granted Critical
Publication of ATE335732T1 publication Critical patent/ATE335732T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT03810562T 2002-11-08 2003-11-04 4-imidazol-1-ylmethylpyrimidinderivate als liganden für gabaa-rezeptoren ATE335732T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42494502P 2002-11-08 2002-11-08

Publications (1)

Publication Number Publication Date
ATE335732T1 true ATE335732T1 (de) 2006-09-15

Family

ID=32312901

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03810562T ATE335732T1 (de) 2002-11-08 2003-11-04 4-imidazol-1-ylmethylpyrimidinderivate als liganden für gabaa-rezeptoren

Country Status (9)

Country Link
US (1) US6951864B2 (de)
EP (1) EP1560822B1 (de)
JP (1) JP2006508102A (de)
AT (1) ATE335732T1 (de)
AU (1) AU2003276514A1 (de)
CA (1) CA2495708A1 (de)
DE (1) DE60307499T2 (de)
ES (1) ES2268488T3 (de)
WO (1) WO2004041808A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100579579C (zh) 2002-10-01 2010-01-13 诺华疫苗和诊断公司 抗癌及抗感染性疾病组合物及其使用方法
CA2508731A1 (en) 2003-02-19 2004-09-02 Neurogen Corporation Aryl acid pyrimidinyl methyl amides, pyridazinyl methyl amides and related compounds
JP2007501272A (ja) * 2003-05-05 2007-01-25 ニューロジェン・コーポレーション 置換イミダゾロピラジンおよびトリアゾロピラジン誘導体類：ｇａｂａａレセプタリガンド類
WO2005012306A2 (en) 2003-07-25 2005-02-10 Neurogen Corporation Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands
KR101170925B1 (ko) 2004-06-18 2012-08-07 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 암 치료용 키네신 방추 단백질 (ｋｓｐ) 억제제로서의ｎ-(1-(1-벤질-4-페닐-1ｈ-이미다졸-2-일)-2,2-디메틸프로필)벤자미드 유도체 및 관련 화합물
JP2010515687A (ja) 2007-01-05 2010-05-13 ノバルティス アーゲー キネシンスピンドルタンパク質阻害剤（ｅｇ−５）としてのイミダゾール誘導体
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8535601A1 (es) * 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
US7030128B2 (en) * 2001-03-23 2006-04-18 Merck Sharp & Dohme Ltd. Imidazo-pyrimidine derivatives as ligands for GABA receptors
CN100579579C (zh) 2002-10-01 2010-01-13 诺华疫苗和诊断公司 抗癌及抗感染性疾病组合物及其使用方法

Also Published As

Publication number Publication date
EP1560822A1 (de) 2005-08-10
ES2268488T3 (es) 2007-03-16
US6951864B2 (en) 2005-10-04
DE60307499D1 (de) 2006-09-21
US20040102457A1 (en) 2004-05-27
WO2004041808A1 (en) 2004-05-21
EP1560822B1 (de) 2006-08-09
AU2003276514A1 (en) 2004-06-07
CA2495708A1 (en) 2004-05-21
DE60307499T2 (de) 2007-02-01
JP2006508102A (ja) 2006-03-09

Similar Documents

Publication Publication Date Title
WO2007133561A3 (en) Substituted azaspiro derivatives
IL193765A0 (en) Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
WO2006052546A3 (en) Pyrazolylmethyl heteroaryl derivatives
WO2006089076A3 (en) Thiazole amides, imidazole amides and related analogues
TW200716594A (en) Substituted heteroaryl CB1 antagonists
AP1503A (en) Benzimidazole and pyridylimidazole derivatives as ligands for GABA receptors
TW200609219A (en) Aryl-substituted piperazine derivatives
WO2005110982A3 (en) Substituted 1-benzyl-4-substituted piperazine analogues
WO2005042498A3 (en) 4-amino (aza) quinoline derivatives as capsaicin receptor agonists
WO2007016496A3 (en) Dipiperazinyl ketones and related analogues
MXPA05006123A (es) Analogos de quinazolin-4-ilamina 2-sustituida como moduladores de receptores de capsaicina.
WO2007146122A3 (en) Tetrahydropyrido[3,4-d]pyrimidines and related analogues
WO2006049941A3 (en) Diaryl ureas as cb1 antagonists
SG157399A1 (en) Substituted biaryl piperazinyl-pyridine analogues
BRPI0413326A (pt) métodos para tratar doença cardiovasculares empregando-se uma molécula ctla4 solúvel
WO2009003003A3 (en) Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues
WO2006076646A3 (en) Heteroaryl substituted quinolin-4-ylamine analogues
TW200621251A (en) Substituted biaryl quinolin-4-ylamine analogues
TW200510373A (en) Substituted quinolin-4-ylamine analogues
MA30720B1 (fr) Analogues de 2-phenoxypyrimidinone
WO2008033739A3 (en) Benzimidazole carboxamide derivatives
WO2006071538A3 (en) Substituted biaryl analogues
WO2009100120A3 (en) Pyridinyl-substituted piperazinyl oxoethyl tetrahydropyrazolopyridines
DE60307499D1 (de) 4-imidazol-1-ylmethylpyrimidinderivate als liganden für gabaa-rezeptoren
WO2004041809A3 (en) Substituted imidazolylmethyl pyridine and pyrazine derivatives and their use as gabaa receptor ligands

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1560822

Country of ref document: EP

REN Ceased due to non-payment of the annual fee